Weight Loss Associated With Improvements in Migraine in Obese Individuals
Individuals with migraine who are obese may have reduced migraine frequency, lower pain intensity, shorter attack duration, and improved disability after losing weight.
All articles by Florence Chaverneff, PhD
Weight Loss Associated With Improvements in Migraine in Obese Individuals
Individuals with migraine who are obese may have reduced migraine frequency, lower pain intensity, shorter attack duration, and improved disability after losing weight.
Transcutaneous Electrical Nerve Stimulation Reduces Pain, Fatigue in Fibromyalgia
Transcutaneous electrical nerve stimulation administered during physical activity may effectively alleviate fibromyalgia-associated pain, fatigue, and disease impact in women.
Benefits of a Pain and Stress Management Program for the Management of Chronic Pain
A “Pain and Stress Management” program for the management of chronic pain, was found to be effective in alleviating pain, diminishing stress, promoting self-management of pain, and ameliorating general well-being.
Eptinezumab May Provide Fast, Effective Reduction of Monthly Migraine Days
Eptinezumab has shown 100% bioavailability when administered intravenously.
Fremanezumab May Help Reduce Medication Overuse in Chronic Migraine
Treatment with fremanezumab may help reduce medication overuse and the number of days of acute medication use in individuals with chronic migraine.
Chronic Migraine Associated With Age-Related Changes in Cortical Thickness
Individuals with chronic migraine may present with age-related changes in cortical thickness.
Pain, Psychiatric Comorbidities More Common in Chronic vs Episodic Migraine
Individuals with chronic vs episodic migraine may be more likely to experience chronic back pain, chronic pain, neck pain, anxiety, and depression.
Eptinezumab for Frequent Episodic Migraine: Results of Phase 3 PROMISE-1 Study
Eptinezumab, a humanized monoclonal antibody specific to calcitonin gene-related peptide, may be an effective prophylactic for individuals with frequent episodic migraines.
Low Vitamin D in Obesity Not Associated With Risk for Multiple Sclerosis
Obesity-associated lowering of vitamin D levels may not mediate the putative causal relationship between obesity and multiple sclerosis.
Next post in ACTRIMS 2018
